GENERAL ATLANTIC, L.P.
New York, NY · CIK 1017645 · 13F filing filed 2024-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityGENERAL ATLANTIC, L.P. (US)
- Others nearbyNew York, NY
Holdings, Q2 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| XP INC XP | $521.0m16.38% | Unchanged |
| DLOCAL LTD DLO | $517.0m16.26% | Unchanged |
| ALKAMI TECHNOLOGY INC ALKT | $489.5m15.39% | Reduced -1.5m |
| ALIGNMENT HEALTHCARE INC ALHC | $477.0m15.00% | Unchanged |
| SQUARESPACE INC SQSP | $463.0m14.56% | Unchanged |
| PHARVARIS N V PHVS | $141.6m4.45% | Unchanged |
| EUROPEAN WAX CTR INC EWCZ | $130.2m4.09% | Unchanged |
| AKERO THERAPEUTICS INC AKRO | $122.8m3.86% | Unchanged |
| CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | $87.4m2.75% | Unchanged |
| BLEND LABS INC BLND | $45.2m1.42% | Unchanged |
| IMMUNOCORE HLDGS PLC IMCR | $42.8m1.34% | Reduced -245.0k |
| ROYALTY PHARMA PLC RPRX | $39.6m1.24% | Unchanged |
| THIRD HARMONIC BIO INC COM | $38.5m1.21% | Unchanged |
| RISKIFIED LTD RSKD | $34.0m1.07% | Unchanged |
| ACELYRIN INC COM | $12.7m0.40% | Unchanged |
| OPENDOOR TECHNOLOGIES INC OPEN | $11.6m0.37% | Unchanged |
| CONTEXTLOGIC INC LOGC | $3.5m0.11% | Unchanged |
| GROVE COLLABORATIVE HOLD INC GROV | $1.7m0.05% | Unchanged |
| ADAGENE INC ADAG | $807.8k0.03% | Unchanged |
Sold out since Q1 2024
| Security | Value then |
|---|---|
| HIRERIGHT HOLDINGS CORPORATI | $458.2m32.1m shares |
| HUTCHMED CHINA LTD HCM | $67.2m4.0m shares |
| MOBILEYE GLOBAL INC MBLY | $38.4m1.2m shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| DLOCAL LTD DLO · 13D · filed 2026-08-19 | 21.4%≈ $478.4m |
| ALKAMI TECHNOLOGY INC ALKT · 13D · filed 2026-05-15 | 18.1%≈ $351.9m |
| LIFTOFF MOBILE INC LFTO · 13D · filed 2026-06-12 | 15.0%≈ $608.1m |
| SEAPORT THERAPEUTICS INC SPTX · 13D · filed 2026-05-11 | 11.5%≈ $132.5m |
| AKERO THERAPEUTICS INC AKRO · 13G · filed 2025-05-15 | 8.4% |
| PHARVARIS N V PHVS · 13G · filed 2026-08-14 | 7.6%≈ $185.3m |
| CHIME FINL INC CHYM · 13G · filed 2025-11-10 | 5.6%≈ $393.4m |
| XP INC XP · 13D · filed 2025-12-04 | 5.4%≈ $370.1m |
Trades reported as a company insider in Q2 2024
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2024-05-07 | ALKAMI TECHNOLOGY INC Director · See footnote | Sold | $40.9m1.5m shares |